Beckman CEO Resigns As Company Faces Regulatory Challenges

Beckman Coulter announced the resignation of Scott Garrett as chairman, president and CEO Sept. 7 as the firm tries to recover from a recent FDA-triggered diagnostic test market withdrawal and ongoing regulatory scrutiny

More from Archive

More from Medtech Insight